About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $37.01 (-1.57%)
NBTXNASDAQNanobiotix
Nanobiotix share price
NBTX price activity
Last Price
$37.010
Change (24hr)
-0.59 USD (-1.57%)
Volume
93.63K
Volume (4w avg)
-
Open
$37.00
Day Range
$36.50 - $37.70
Previous Close
$37.60
Last Trade
11 Sep, 8:00 pm GMT+0
Delayed
11 Sep, 8:00 pm GMT+0
NBTX price performance
Delayed
11 Sep, 8:00 pm GMT+0
NBTX Market Signals